NewsBenzingaPiper Sandler ribadisce il giudizio Overweight su Microsoft e alza il target di prezzo a 650 dollari Piper Sandler ribadisce il giudizio Overweight su Microsoft e alza il target di prezzo a 650 dollari Benzinga 2026.10.29 09:20 (GMT+0) Open on Benzinga Other news Building A 7%-Yielding Dividend Growth Portfolio With SCHD As Its Core Holding Lilly raises outlook for third time this year as Zepbound sales soar WPP plc (WPP) Q3 2026 Sales/ Trading Statement Call - Slideshow (NYSE:WPP) 2026-10-29 AutoZone's Q1 2027 Earnings: What to Expect Shopify Bull Put Spread Could Return 25% Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
